참고문헌
- Agarwal R, Mori Y, Cheng Y, et al (2009). Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells. PLoS One, 4, 8002. https://doi.org/10.1371/journal.pone.0008002
- Boireau S, Buchert M, Samuel MS, et al (2007). DNAmethylation- dependent alterationsof claudin-4 expression in human bladder carcinoma. Carcinogenesis, 28, 246-58. https://doi.org/10.1093/carcin/bgl120
- Borka K, Kaliszky P, Szabo E, et al (2007). Claudin expression in pancreatic endocrine tumors as compared with ductal adenocarcinomas. Virchows Arch, 450, 549-57. https://doi.org/10.1007/s00428-007-0406-7
- Bornholdt J, Friis S, Godiksen S, et al (2011). The level of Claudin-7 is reduced as an early event in colorectal carcinogenesis. BMC Cancer, 11, 65. https://doi.org/10.1186/1471-2407-11-65
- Bunthot S, Obchoei S, Kraiklang R, et al (2012). Overexpression of claudin-4 in cholangiocarcinoma tissues and its possible role in tumor metastasis. Asian Pac J Cancer Prev, 13, 71-6.
- Comper F, Antonello D, Beghelli S, et al (2009). Expression pattern of claudins 5 and 7 distinguishes solidpseudopapillaryfrom pancreatoblastoma, acinar cell and endocrinetumors of the pancreas. Am J Surg Pathol, 33, 768-74. https://doi.org/10.1097/PAS.0b013e3181957bc4
- Dehghan Esmatabadi MJ, Farhangi B, Safari Z, et al (2015). Dendrosomal curcumin inhibits metastatic potential of human SW480 colon cancer cells through down-regulation of Claudin1, Zeb1 and Hef1-1 gene expression. Asian Pac J Cancer Prev, 16, 2473-81. https://doi.org/10.7314/APJCP.2015.16.6.2473
- Eskelinen MJ, Haglund UH (1999). Prognosis of human pancreaticadenocarcinoma: review of clinical and histopathological variablesand possible uses of new molecular methods. Eur J Surg, 165, 292-306. https://doi.org/10.1080/110241599750006811
- Fritzsche FR, Oelrich B, Johannsen M, et al (2008). Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas. Clin Cancer Res, 14, 7035-42. https://doi.org/10.1158/1078-0432.CCR-08-0855
- Hsueh C, Chang YS, Tseng NM, et al (2010). Expression pattern and prognostic significance of claudins 1, 4, and 7 innasopharyngeal carcinoma. Hum Pathol, 41, 944-50 https://doi.org/10.1016/j.humpath.2010.01.005
- Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300. https://doi.org/10.3322/caac.20073
- Karanjawala ZE, Illei PB, Ashfaq R, et al (2008). New markers of pancreatic cancer identified through differentialgene expression analyses: claudin 18 and annexin A8. Am JSurg Pathol, 32, 188-96. https://doi.org/10.1097/PAS.0b013e31815701f3
- Kojima T, Takano K, Yamamoto T, et al (2008). Transforming growth factor-beta induces epithelial to mesenchymal transition by down-regulation of claudin-1 expression and the fence function in adult rat hepatocytes. Liver Int, 28, 534-45.
- Kojima T, Sawada N (2012). Regulation of tight junctions in human normal pancreatic duct epithelial cells and cancer cells. Ann N Y Acad Sci, 1257, 85-92. https://doi.org/10.1111/j.1749-6632.2012.06579.x
- Kojima T, Kyuno D, Sawada N (2012). Targeting claudin-4 in human pancreatic cancer. Expert Opin Ther Targets, 16, 881-7. https://doi.org/10.1517/14728222.2012.708340
- Kominsky SL, Argani P, Korz D, et al (2003). Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene, 22, 2021-33. https://doi.org/10.1038/sj.onc.1206199
- Kondo J, Sato F, Kusumi T, et al (2008). Claudin-1 expression is induced by tumor necrosis factor-alpha in human pancreatic cancer cells. Int J Mol Med, 22, 645-9.
- Konecny GE, Agarwal R, Keeney GA, et al (2008). Claudin-3 and Claudin-4 expression in serous papillary, clear cell, and endometrioid endometrial cancer. Gynecol Oncol, 109, 263-9. https://doi.org/10.1016/j.ygyno.2008.01.024
- Krause G, Winkler L, Mueller SL, et al (2008). Structure and function of Claudins. Biochim Biophys Acta, 1778, 631-45. https://doi.org/10.1016/j.bbamem.2007.10.018
- Kwon MJ, Kim SS, Choi YL, et al (2010). Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated withloss of repressive histone modifications. Carcinogenesis, 31, 974-983. https://doi.org/10.1093/carcin/bgp336
- Kwon MJ, Kim SH, Jeong HM, et al (2011). Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma. Lab Invest, 91, 1652-67. https://doi.org/10.1038/labinvest.2011.117
-
Kyuno D, Kojima T, Yamaguchi H, et al (2013). Protein kinase
$C{\alpha}$ inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pancreatic cancer. Carcinogenesis, 34, 1232-43. https://doi.org/10.1093/carcin/bgt057 - Landers KA, Samaratunga H, Teng L, et al (2008). Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. Br J Cancer, 99, 491-501. https://doi.org/10.1038/sj.bjc.6604486
- Lechpammer M, Resnick MB, Sabo E, et al (2008). The diagnostic and prognostic utility of claudin expression in renal cell neoplasms. Mod Pathol. 21, 1320-9. https://doi.org/10.1038/modpathol.2008.116
- Michl P, Barth C, Buchholz M, et al (2003). Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res, 63, 6265-71.
- Neesse A, Griesmann H, Gress TM, Michl P (2012). Claudin-4 as therapeutic target in cancer. Arch Biochem Biophys, 524, 64-70. https://doi.org/10.1016/j.abb.2012.01.009
- Neesse A, Hahnenkamp A, Griesmann H, et al (2013). Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions. Gut, 62, 1034-43. https://doi.org/10.1136/gutjnl-2012-302577
- Nichols LS, Ashfaq R, Iacobuzio-Donahue CA (2004). Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol, 121, 226-30. https://doi.org/10.1309/K144PHVDDUPDD401
- Oliveira SS, Morgado-Diaz JA (2007). Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci, 64, 17-28. https://doi.org/10.1007/s00018-006-6314-1
- Ouban A, Ahmed AA (2010). Claudins in human cancer: a review. Histol Histopathol, 25, 83-90.
- Pan XY, Wang B, Che YC, et al (2007). Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue. Int J Gynecol Cancer, 17, 233-241. https://doi.org/10.1111/j.1525-1438.2006.00748.x
- Rahner C, Mitic L, Anderson JM (2001). Heterogenity in expression and subcellu¬lar localization of Claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology, 120, 411-22. https://doi.org/10.1053/gast.2001.21736
- Rangel LB, Agarwal R, D'Souza T, et al (2003). Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res, 9, 2567-75.
- Sheehan GM, Kallakury BV, Sheehan CE, et al (2007). Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum Pathol, 38, 564-9. https://doi.org/10.1016/j.humpath.2006.11.007
- Singh AB, Sharma A, Dhawan P(2010). Claudin family of proteins and cancer: an overview. J Oncol, 2010, 541957.
- Soini Y, Takasawa A, Eskelinen M, et al (2012). Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation. J Clin Pathol, 65, 431-6. https://doi.org/10.1136/jclinpath-2011-200400
- Szekely E, Torzsok P, Riesz P, et al (2011). Expression of claudins and their prognostic significance in noninvasive urothelial neoplasms of the human urinary bladder. J Histochem Cytochem, 59, 932-41. https://doi.org/10.1369/0022155411418829
- Tan C, Cruet-Hennequart S, Troussard A, et al (2004). Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell, 5, 79-90. https://doi.org/10.1016/S1535-6108(03)00281-2
- Tsukahara M, Nagai H, Kamiakito T, et al (2005). Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas. Pathol Int, 55, 63-9. https://doi.org/10.1111/j.1440-1827.2005.01793.x
- Tsukita S, Furuse M, Itoh M (2001). Multifunctional strands in tight junctions. Nature Reviews Molecular Cell Biology, 2, 285-93. https://doi.org/10.1038/35067088
- Tsutsumi K, Sato N, Tanabe R, et al (2012). Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. Ann Surg Oncol, 3, 491-9.
- Usami Y, Chiba H, Nakayama F, et al (2006). Reduced expression of Claudin-7 cor-relates with invasion and metastasis in squamous cell carcinoma of the esophagus. Human Pathology, 37, 569-77. https://doi.org/10.1016/j.humpath.2005.12.018
- Wang WJ, Qin SH, Zhang JW, et al (2014). Combination doxorubicin and interferon-α therapy stimulates immunogenicity of murine pancreatic cancer Panc02 cells via up-regulation of NKG2D ligands and MHC class I. Asian Pac J Cancer Prev, 15, 9667-72. https://doi.org/10.7314/APJCP.2014.15.22.9667
- Westmoreland JJ, Drosos Y, Kelly J et al. (2012).Dynamic distribution of claudin proteins in pancreatic epithelia undergoing morphogenesis or neoplastic transformation. Dev Dyn, 241, 583-94. https://doi.org/10.1002/dvdy.23740
- Will C, Fromm M, Muller D (2008). Claudin tight junction proteins: novel aspects in paracellular transport. Perit Dial Int, 28, 577-84.
- Yeo TP, Hruban RH, Leach SD, et al (2002). Pancreatic cancer. Curr Probl Cancer, 26, 176-275. https://doi.org/10.1067/mcn.2002.129579
- Yoon CH, Kim MJ, Park MJ, et al (2010). Claudin-1 acts through c-Abl-protein kinase Cdelta (PKCdelta) signaling and has a causal role in the acquisition of invasive capacity in human liver cells. J Biol Chem, 285, 226-33. https://doi.org/10.1074/jbc.M109.054189
피인용 문헌
- Expression of claudin 1, 4 and 7 in thyroid neoplasms vol.13, pp.5, 2017, https://doi.org/10.3892/ol.2017.5916